Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder

Journal of Affective Disorders

Volumn 107, Issue 1-3, 2008, Pages 145-154

  Suppes, Trisha ^a   Eudicone, James ^b   McQuade, Robert ^c   Pikalov III, Andrei ^c   Carlson, Berit ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c Otsuka America Pharmaceutical Inc   (United States)

Author keywords

Acute mixed or manic episodes; Aripiprazole; Bipolar I disorder

Indexed keywords

ARIPIPRAZOLE;

ACCIDENTAL INJURY; ADULT; AGITATION; AKATHISIA; ANXIETY; ARTICLE; BACKACHE; BIPOLAR DISORDER; BLURRED VISION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERSALIVATION; INFECTION; INSOMNIA; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SOMNOLENCE; SYMPTOMATOLOGY; TREMOR; VOMITING; XEROSTOMIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 39649111540     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.08.015     Document Type: Article

References (30)

1. Adityanjee, and Shultz S.C. Clinical use of quetiapine in disease states other than schizophrenia. J. Clin. Psychiatry 63 Suppl 13 (2002) 32-38
2. Baker R.W., Tohen M., Fawcett J., Risser R.C., Schuh L.M., Brown E., Stauffer V.L., Shao L., and Tollefson G.D. Acute dysphoric mania: treatment response to olanzapine vs placebo. J. Clin. Psychopharmacol. 23 (2003) 132-137
3. Baldessarini R.J., Hennen J., Wilson M., Calabrese J., Chengappa R., Keck Jr. P.E., McElroy S.L., Sachs G., Vieta E., Welge J.A., Yatham L.N., Zarate Jr. C.J., Baker R.W., and Tohen M. Olanzapine vs placebo in acute mania: treatment responses in subgroups. J. Clin. Psychopharmacol. 23 (2003) 370-376
4. Bauer M., and Pfenning A. Epidemiology of bipolar disorder. Epilepsia 46 Suppl 4 (2005) 8-13
5. Chengappa K.N., Baker R.W., Shao L., Yatham L.N., Tohen M., Gershon S., and Kupfer D.J. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord. 5 (2003) 1-5
6. Data on file. Otsuka America Pharmaceutical, Inc., Rockville, MD; April 2003.
7. Ghaemi S.N., Hsu D.J., Rosenquist K.J., Pardo T.B., and Goodwin F.K. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Prog. Neuro-psychopharmacol. Biol. Psychiatry 30 (2006) 209-213
8. Hirschfeld M.A., Lewis L., and Vornik L.A. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association. 2000. Survey of individuals with bipolar disorder. J. Clin. Psychiatry 64 (2003) 161-174
9. Hirschfeld R.M., Keck Jr. P.E., Kramer M., Karcher K., Canuso C., Eerdekens M., and Grossman F. Rapid antimanic effect of risperidone monotherapy: a 3-week, multicentre, double-blind, placebo-controlled study. Am. J. Psychiatry 161 (2004) 1057-1065
10. Keck Jr. P.E., Versiani M., Potkin S., West S.A., Giller E., Ice K., and Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry 160 (2003) 741-748
11. Keck Jr. P.E., Marcus R., Tourkodimitris S., Ali M., Liebeskind A., Saha A., Ingenito G., and Aripiprazole Study Group. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am. J. Psychiatry 160 (2003) 1651-1658
12. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005) 593-602
13. Khanna S., Vieta E., Lyons B., Grossman F., Eerdekens M., and Kramer M. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br. J. Psychiatry 187 (2005) 229-234
14. Kupfer D.J., Frank E., Grochocinski V.J., Cluss P.A., Houck P.R., and Stapf D.A. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J. Clin. Psychiatry 63 (2002) 120-125
15. Perlis R.H., Ostacher M.J., Patel J.K., Marangell L.B., Zhang H., Wisniewski S.R., Ketter T.A., Miklowitz D.J., Otto M.W., Gyulai L., Reilly-Harrington N.A., Nierenberg A.A., Sachs G.S., and Thase M.E. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 163 (2006) 217-224
16. Post R. The impact of bipolar depression. J. Clin. Psychiatry 66 Suppl 5 (2005) 5-10
17. Sachs G., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Impellizzeri C., Kaplita S., Rollin L., Iwamoto T., and Aripiprazole Study Group. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J. Psychopharmacol. 20 (2006) 536-546
18. Sanger T.M., Tohen M., Vieta E., Dunner D.L., Bowden C.L., Calabrese J.R., Feldman P.D., Jacobs T.G., and Breier A. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J. Affect. Disor. 73 (2003) 155-161
19. Schneck C.D., Miklowitz D.J., Calabrese J.R., Allen M.H., Thomas M.R., Wisniewski S.R., Miyahara S., Shelton M.D., Ketter T.A., Goldberg J.F., Bowden C.L., and Sachs G.S. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am. J. Psychiatry 10 (2004) 1902-1918
20. Suppes, T., Brown, E., Schuh, L.M., Baker, R.W., Tohen, M., 2005. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. J. Affect. Disord. 89, 69-77 (Epub 2005 Oct 25).
21. Swann A.C., Bowden C.L., Morris D., Calabrese J.R., Petty F., Small J., Dilsaver S.C., and Davis J.M. Depression during mania. Treatment response to lithium or divalproex. Arch. Gen. Psychiatry 54 (1997) 37-42
22. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., and Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 156 (1999) 702-709
23. Tohen M., Jacobs T.G., Grundy S.L., McElroy S.L., Banov M.C., Janicak P.G., Sanger T., Risser R., Zhang F., Toma V., Francis J., Tollefson G.D., and Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch. Gen. Psychiatry 57 (2000) 841-849
24. Tondo L., Hennen J., and Baldessarini R.J. Meta-analysis of treatment responses of rapid-cycling and non-rapid-cycling bipolar disorder patients. Acta Psychiatr. Scand. 104 (2003) 4-14
25. Vieta E. Bipolar mixed states and their treatment. Expert Rev. Neurother. 5 (2005) 63-68
26. Vieta E., Calabrese J.R., Hennen J., Colom F., Martinez-Aran A., Sanchez-Moreno J., Yatham L.N., Tohen M., and Baldessarini R.J. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J. Clin. Psychiatry 65 (2004) 1420-1428
27. Vieta E., Bourin M., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Swanink R., Iwamoto T., and on behalf of the Aripiprazole Study Group. Effectiveness of aripiprazole vs haloperidol in acute bipolar mania: double-blind, randomized, comparative 12-week trial. Br. J. Psychiatry 187 (2005) 235-242
28. Weisler R.H., Kalali A.H., Ketter T.A., and for the SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J. Clin. Psychiatry 65 (2004) 478-484
29. Weisler R.H., Keck Jr. P.E., Swann A.C., and SPD417 Study Group. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry 66 (2005) 323-330
30. Yildiz A., and Sachs G.S. Characteristics of rapid cycling bipolar-I patients in a bipolar specialty clinic. J. Affect. Disord. 79 (2004) 247-251